# FDA Inspection 1006525 - Northeast Laboratories, Inc. - March 29, 2017

Source: https://www.keypedia.com/records/fda_inspections/northeast-laboratories-inc/3f5a1487-d4ea-4559-a8b5-8e94fb9f1696
Source feed: FDA_Inspections

> FDA Inspection 1006525 for Northeast Laboratories, Inc. on March 29, 2017. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1006525
- Company Name: Northeast Laboratories, Inc.
- Inspection Date: 2017-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1229261 - 2024-01-11](https://www.keypedia.com/records/fda_inspections/northeast-laboratories-inc/e31b6bf7-2f63-417f-b030-b22120ec14bf)
- [FDA Inspection 755765 - 2011-12-02](https://www.keypedia.com/records/fda_inspections/northeast-laboratories-inc/bd23511e-0cff-43fd-9885-4c57530d26b9)
- [FDA Inspection 643538 - 2010-02-04](https://www.keypedia.com/records/fda_inspections/northeast-laboratories-inc/e0ce410a-034c-4a5a-8430-89819c11cbb5)

Company: https://www.keypedia.com/companies/northeast-laboratories-inc/654f5a93-eab8-4f03-8318-d7fff80e9523

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c